Lv1
40 积分 2024-09-23 加入
Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib
4个月前
已完结
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan, and South Korea with moderate to severe plaque psoriasis: a phase 3 randomized clinical trial
5个月前
已完结
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis For Up to 3 Years
5个月前
已完结
Acneiform Eruption Secondary to Deucravacitinib: A Case Series and Review of the Literature
5个月前
已完结
Alopecia areata
6个月前
已完结
The impact of biologics targeting the IL-17 and IL-23 pathways on metabolic indicators in plaque psoriasis
6个月前
已完结
Compounds of psoriasis with obesity and overweight
7个月前
已关闭
0469 The association between bariatric surgery and improvement in psoriasis: A systematic review
7个月前
已关闭
Effects of six months treatment with liraglutide among patients with psoriasis and obesity, beyond metabolic control?
7个月前
已关闭
皖公网安备34019202002308
